Found: 4
Select item for more details and to access through your institution.
Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma.
- Published in:
- Cancer Nanotechnology (1868-6958), 2023, v. 14, n. 1, p. 1, doi. 10.1186/s12645-023-00213-7
- By:
- Publication type:
- Article
Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8<sup>+</sup> T cells in early clinical stages of chronic lymphocytic leukemia.
- Published in:
- Immunologic Research, 2020, v. 68, n. 5, p. 269, doi. 10.1007/s12026-020-09146-4
- By:
- Publication type:
- Article
Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An in vitro study.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 3, p. 704, doi. 10.4103/jcrt.jcrt_52_21
- By:
- Publication type:
- Article
Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An study.
- Published in:
- 2022
- By:
- Publication type:
- journal article